Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

NCT02767596 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment rate

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Lixisenatide
DRUG: Basal insulins

Sponsor

Laniado Hospital